Klaudia Kuranda

Klaudia Kuranda

Company: Spark Therapeutics

Job title: Head of Immunocolgy


Klaudia Kuranda is the Head of Immunology at Spark Therapeutics, part of the Roche Group, an industry leader in gene therapy. Klaudia leads efforts focused on AAV immunogenicity risk assessment for programs spanning Liver, CNS and Ocular therapeutic areas, develops strategies to modulate vector immunogenicity using preclinical models and designs novel gene therapy approaches for immune-related disease.

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.